HIV In-home Test Tax Exemption Amendment Act of 2025

26th Council Period (2025-2026) Introduced by Brooke Pinto

DC would exempt HIV in-home test kits from sales tax, lowering costs for buyers and expanding access to at-home HIV testing.

Re-Referred to Committee of the Whole with comments from the Committee on Health

Summary: HIV In-home Test Tax Exemption Amendment Act of 2025 (B 26-0099)

Overview
- Bill number: B 26-0099
- Title: HIV In-home Test Tax Exemption Amendment Act of 2025
- Jurisdiction: District of Columbia
- Introduced: January 30, 2025
- Sponsor: Councilmember Pinto
- Classification: Legislative bill
- Current status: Notice of Intent to Act on B26-0099 published in the DC Register

What the bill aims to do
- Based on the title, the bill seeks to amend the District of Columbia’s tax exemption framework to provide or expand a tax exemption for HIV in-home test kits.
- The intended effect is to reduce or eliminate sales/use taxes on HIV at-home testing products, thereby lowering the out-of-pocket cost for consumers purchasing these kits within DC.

Key provisions (as inferred from the bill’s title and status)
- Tax policy change: Modify the DC tax code to establish or broaden a tax exemption specifically for HIV in-home test kits.
- Scope of exemption: The exact definitions, eligible products, and conditions are not provided in the available information. Typically, such provisions would define what qualifies as an “in-home HIV test,” who is eligible (consumers, retailers, or clinics), and any limitations or sunset provisions.
- Effective date: Not specified in the provided materials; such details are usually addressed in the enacted text or later amendments.
- Administrative details: The bill would ordinarily specify administrative implementation, enforcement responsibilities, and any reporting requirements, but these specifics are not included in the current summary.

Who would be affected
- Consumers in DC who purchase HIV in-home test kits would potentially benefit from a tax exemption.
- Retailers, pharmacies, and distributors selling HIV in-home test kits in DC would be affected by the exemption’s applicability and compliance requirements.
- Public health stakeholders could see indirect benefits from improved access to testing.

Legislative timeline and actions
- January 30, 2025: Introduced by Councilmember Pinto, Office of the Secretary.
- February 4, 2025: Referred to the Committee on Business and Economic Development with comments from the Committee on Health.
- February 7, 2025: Notice of Intent to Act on B26-0099 published in the DC Register, indicating the Council intends to take further action on the bill.

Potential impact and considerations
- Access and affordability: If enacted, the tax exemption could reduce the cost barrier to at-home HIV testing, potentially increasing testing uptake and early detection.
- Public health implications: Broader access to testing can support timely diagnosis and linkage to care for HIV.
- Implementation: The effectiveness of the exemption will depend on the bill’s precise definitions and administrative rules, including which products qualify and how retailers claim the exemption.

Notes
- The exact text of provisions, definitions, and any sunset clauses or fiscal notes are not provided in the available information. Readers should review the enacted bill text and DC Register notices for precise language and effective dates once published.